Janet Hopkins
Direttore Tecnico/Scientifico/R&S presso AURA BIOSCIENCES, INC.
Patrimonio netto: 1 M $ in data 31/05/2024
Posizioni attive di Janet Hopkins
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Direttore/Membro del Consiglio | 17/02/2022 | - |
| AURA BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 16/10/2023 | - |
Storia della carriera di Janet Hopkins
Precedenti posizioni note di Janet Hopkins
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/11/2021 | 01/10/2023 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Amministratore Delegato | 01/12/2021 | 01/10/2023 |
Formazione di Janet Hopkins
| McMaster University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
| Stati Uniti | 2 |
| Svizzera | 2 |
Posizioni
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AURA BIOSCIENCES, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Aziende private | 2 |
|---|---|
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Janet Hopkins
- Esperienza
